Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Fentanyl for Chronic Cancer Pain
NCT00236327Phase 4Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2003
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of fentanyl in cancer pain, sponsored by Janssen Pharmaceutical. Started Jun 2003; status: terminated.
02
Drugs
fentanyl
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00236327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00236327.